Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mann

Showing results (1051-1060 of 1,096) with videos related to

Pageof 110
Sort By:
Hypertension (Dallas, Tex. : 1979)|June 5, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood PressureRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Lancet (London, England)|August 19, 2008
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialJohannes F E Mann, Roland E Schmieder, Matthew McQueen, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and FinerenoneRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Cardiovascular Engineering and Technology|August 28, 2021
Cycle Length Evaluation in Persistent Atrial Fibrillation Using Kernel Density Estimation to Identify Transient and Stable Rapid Atrial ActivitySzabolcs Z Nagy, Patrick Kasi, Valtino X Afonso, et al.
Annals of Internal Medicine|May 20, 2009
Effect of telmisartan on renal outcomes: a randomized trialJohannes F E Mann, Roland E Schmieder, Leanne Dyal, et al.
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
American Journal of Physical Anthropology|December 27, 2018
The efficacy of whole human genome capture on ancient dental calculus and dentinKirsten A Ziesemer, Jazmín Ramos-Madrigal, Allison E Mann, et al.
Journal for Immunotherapy of Cancer|September 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetesLilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto, et al.
Plos One|February 26, 2008
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalMaria Teresa Landi, Tatiana Dracheva, Melissa Rotunno, et al.
Psychiatry Research|March 6, 2019
Moderate to severe gambling problems and traumatic brain injury: A population-based studyNigel E Turner, André J McDonald, Anca R Ialomiteanu, et al.
Pageof 110

Showing results (1051-1060 of 1,096) with videos related to

Sort By:
Pageof 110
Hypertension (Dallas, Tex. : 1979)|June 5, 2026
Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood PressureRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Lancet (London, England)|August 19, 2008
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trialJohannes F E Mann, Roland E Schmieder, Matthew McQueen, et al.
Journal of the American Society of Nephrology : JASN|March 29, 2026
Acute eGFR Changes and Their Mediation of Albuminuria Reduction with Empagliflozin and FinerenoneRajiv Agarwal, Ricardo Correa-Rotter, Sankar D Navaneethan, et al.
Cardiovascular Engineering and Technology|August 28, 2021
Cycle Length Evaluation in Persistent Atrial Fibrillation Using Kernel Density Estimation to Identify Transient and Stable Rapid Atrial ActivitySzabolcs Z Nagy, Patrick Kasi, Valtino X Afonso, et al.
Annals of Internal Medicine|May 20, 2009
Effect of telmisartan on renal outcomes: a randomized trialJohannes F E Mann, Roland E Schmieder, Leanne Dyal, et al.
Circulation|November 13, 2020
Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular DiseaseJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.
American Journal of Physical Anthropology|December 27, 2018
The efficacy of whole human genome capture on ancient dental calculus and dentinKirsten A Ziesemer, Jazmín Ramos-Madrigal, Allison E Mann, et al.
Journal for Immunotherapy of Cancer|September 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetesLilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto, et al.
Plos One|February 26, 2008
Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survivalMaria Teresa Landi, Tatiana Dracheva, Melissa Rotunno, et al.
Psychiatry Research|March 6, 2019
Moderate to severe gambling problems and traumatic brain injury: A population-based studyNigel E Turner, André J McDonald, Anca R Ialomiteanu, et al.
Pageof 110